Medicine and Dentistry
Therapeutic Procedure
100%
microRNA
93%
Combination Therapy
77%
COVID-19
66%
Threat
55%
Quorum Sensing
44%
Oligonucleotide
44%
Clinical Trial
44%
Nucleic Acid
44%
Oligonucleotide Delivery
44%
Short Hairpin RNA
44%
Biological Marker
44%
Laboratory
44%
microRNA 146a
44%
Public Health
44%
Assay
40%
Development
40%
Exercise
33%
Diseases
33%
Hepatitis C Virus
29%
RNA
29%
Tissues
29%
Untranslated RNA
28%
Epidemic
25%
Personalized Medicine
25%
Laboratory Test
22%
Contact Examination
22%
Adoption
22%
Molecular Diagnostics
22%
Diagnosis
22%
Bacillus
22%
Bacillus Licheniformis
22%
Hemorrhagic Fever
22%
Differential Diagnosis
22%
Molecular Diagnosis
22%
Alveolar Macrophage
22%
Cell Penetrating Peptide
22%
Transcytosis
22%
Liposome
22%
Oligonucleotide Therapy
22%
Cytosol
22%
Pulmonary Disorder
22%
Antisense
22%
Toxicity
22%
Health
22%
Lung Physiology
22%
Severe Acute Respiratory Syndrome Coronavirus 2
22%
RNA Interference
22%
Silo-Filler's Disease
22%
Thiamazole
22%
Biochemistry, Genetics and Molecular Biology
Small Interfering RNA
88%
RNA
74%
Cell-Penetrating Peptide
54%
Breathing
44%
MUC5B
44%
Membrane Vesicle
44%
Single-Nucleotide Polymorphism
44%
Protein
40%
Messenger RNA
35%
microRNA
34%
Pheromone
33%
Oligonucleotide
33%
Replicon
29%
Conjugation
27%
Degradation
25%
Kinase
24%
Innate Immunity
24%
Molecule
23%
Rapid Amplification of cDNA Ends
22%
Ligase
22%
Bacillus Licheniformis
22%
Transmission Electron Microscopy
22%
Surface Property
22%
Outer Membrane
22%
DNA
20%
Cholesterol
19%
Matrix-Assisted Laser Desorption-Ionization
19%
Spectroscopy
19%
Biomolecules
17%
Gene Expression
17%
Conjugate
16%
Reduction (Chemistry)
14%
Quasispecies
14%
Dicer
14%
Posttranscriptional Regulation
14%
Primate Model
14%
Regulatory Mechanism
14%
Primate
14%
MicroRNA
14%
Long Non-Coding RNA
14%
High Throughput Sequencing
14%
Surface Area
14%
Phosphate
12%
Next Generation Sequencing
11%
Antifungal Activity
11%
Aspergillus flavus
11%
Fungus Growth
11%
Sampling
11%
Escherichia coli
11%
Quantitative Technique
11%
Pharmacology, Toxicology and Pharmaceutical Science
Oligonucleotide
66%
Muramyl Dipeptide
44%
microRNA
44%
Nucleic Acid
44%
Target Identification
44%
Clinical Trial
44%
microRNA 146a
44%
Risk Assessment
44%
Venom
44%
Drug Discovery
44%
Potassium Alum
37%
Drug
33%
RNA
33%
Drug Development
32%
Pheromone
26%
Givosiran
22%
Ebola Virus
22%
Hemorrhagic Fever
22%
Quil A
22%
Liposome
22%
Cell Penetrating Peptide
22%
Antisense Oligonucleotide
22%
Transcytosis
22%
Antibody
22%
Cell Culture
22%
Lung Disease
22%
Molecular Target
22%
Untranslated RNA
22%
Methimazole
22%
Chitosan
14%
Dipeptide
14%
Naja
12%
Bite Wound
12%
Aspergillus flavus
11%
Genetic Disorder
11%
Drug Repositioning
11%
Animal
11%
Pharmacokinetics
11%
Respiratory Tract Disease
11%
Red Fluorescent Protein
11%
Lipidome
11%
Adult Respiratory Distress Syndrome
11%
Pharmacodynamics
11%
Enalapril Maleate
11%
DNA
11%
Nusinersen
11%
Galactosamine
11%
Patisiran
11%
Asialoglycoprotein Receptor
11%
Mouse
11%